Compare USCB & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | USCB | MASS |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.1M | 498.1M |
| IPO Year | 2021 | 2020 |
| Metric | USCB | MASS |
|---|---|---|
| Price | $19.87 | $11.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $23.25 | $13.38 |
| AVG Volume (30 Days) | 71.1K | ★ 343.8K |
| Earning Date | 10-22-2026 | 11-10-2026 |
| Dividend Yield | ★ 2.52% | N/A |
| EPS Growth | 7.26 | ★ 125.47 |
| EPS | ★ 1.00 | N/A |
| Revenue | N/A | ★ $56,197,000.00 |
| Revenue This Year | $20.63 | $22.97 |
| Revenue Next Year | $7.64 | $19.41 |
| P/E Ratio | $19.85 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.00 | $5.03 |
| 52 Week High | $23.89 | $13.35 |
| Indicator | USCB | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 28.77 | 45.41 |
| Support Level | $19.08 | $11.14 |
| Resistance Level | $20.19 | $11.25 |
| Average True Range (ATR) | 0.61 | 0.65 |
| MACD | -0.24 | -0.03 |
| Stochastic Oscillator | 18.83 | 14.36 |
USCB Financial Holdings Inc is a bank holding company. Through its banking subsidiary, it offers relationship-based banking products, services, and solutions to a diverse set of clients in the local markets it operates in and international clients with U.S. banking needs. The Group's products and services offerings mainly include traditional deposit products, including commercial and consumer checking accounts, money market deposit accounts, savings accounts, etc.; e-banking services; title insurance policies for real estate transactions; and a variety of lending products such as small business loans, commercial real estate loans, business credit cards, etc.; and others. Geographically, its primary banking market is South Florida.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.